Advertisement
Advertisement
NBIX
Neurocrine Biosciences Inc
158.29
USDSponsored
-0.71
-0.45%
Jun 18, 15:59 UTC -4
Closed
After-Market
157.07
-1.22
-0.77%
NBIX Earnings Reports
Positive Surprise Ratio
NBIX beat 17 of 41 last estimates.
41%
Next Report
Date of Next Report
Jul 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$884.08M
/$1.61
Implied change from Q1 26 (Revenue/ EPS)
+8.54%
/-15.71%
Implied change from Q2 25 (Revenue/ EPS)
+28.59%
/+51.89%
Neurocrine Biosciences Inc earnings per share and revenue
On May 05, 2026, NBIX reported earnings of 1.91 USD per share (EPS) for Q1 26, beating the estimate of 1.17 USD, resulting in a 62.26% surprise. Revenue reached 814.50 million, compared to an expected 786.21 million, with a 3.60% difference. The market reacted with a +8.86% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 19 analysts forecast an EPS of 1.61 USD, with revenue projected to reach 884.08 million USD, implying an decrease of -15.71% EPS, and increase of 8.54% in Revenue from the last quarter.
FAQ
What were Neurocrine Biosciences Inc's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Neurocrine Biosciences Inc reported EPS of $1.91, beating estimates by 62.26%, and revenue of $814.50M, 3.6% above expectations.
How did the market react to Neurocrine Biosciences Inc's Q1 2026 earnings?
The stock price moved up 8.86%, changed from $135.06 before the earnings release to $147.02 the day after.
When is Neurocrine Biosciences Inc expected to report next?
The next earning report is scheduled for Jul 28, 2026.
What are the forecasts for Neurocrine Biosciences Inc's next earnings report?
Based on 19
analysts, Neurocrine Biosciences Inc is expected to report EPS of $1.61 and revenue of $884.08M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement